COCHLEAR? VISTAFIX? VXI300 IMPLANT 3MM 93100

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional report with the FDA on 2017-11-22 for COCHLEAR? VISTAFIX? VXI300 IMPLANT 3MM 93100 manufactured by Cochlear Bone Anchored Solutions Ab.

Event Text Entries

[92831279] This report is submitted (b)(6) 2017, by (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[92831280] Per the clinic, the patient experienced skin overgrowth at abutment site; subsequently the patient was placed under general anesthesia and underwent skin revision surgery during an abutment change. The implanted device remains.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number6000034-2017-02167
MDR Report Key7055068
Report SourceHEALTH PROFESSIONAL
Date Received2017-11-22
Date of Report2017-11-16
Date Mfgr Received2017-11-16
Date Added to Maude2017-11-22
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. KRISTEL KOHNE
Manufacturer Street1 UNIVERSITY AVENUE
Manufacturer CityMACQUARIE UNIVERSITY, NSW 2109,
Manufacturer CountryAS
Manufacturer Postal2109,
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCOCHLEAR? VISTAFIX? VXI300 IMPLANT 3MM
Generic NameCOCHLEAR BAHA VISTAFIX SYSTEM
Product CodeFZE
Date Received2017-11-22
Model Number93100
Catalog Number93100
Lot Number98609
OperatorLAY USER/PATIENT
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerCOCHLEAR BONE ANCHORED SOLUTIONS AB
Manufacturer AddressKONSTRUKTIONSV?GEN 14 PO BOX 82 M?LNLYCKE, 435 22 SW 435 22


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2017-11-22

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.